Precision
pathology,
accessible
everywhere

Deciphex
is
building
a
global
network
of
AI
empowered
pathologists,
ensuring
accessible,
innovative
pathology
services
that
improve
patient
outcomes.

Find out more
Find out more
About us
About us

Far-reaching
impact

Freeing up pathologists to focus on complex cases
Lorem ipsum

Democratising access to high quality pathology

Limited pathology resources and increasing diagnostic needs underscore the urgency for scalable solutions. Our unique, global network of elite pathologists, empowered by AI-driven digital workflows, delivers rapid, accurate diagnostics remotely, including select pro-bono support in underserved areas, bridging essential healthcare gaps.

Read article
Read article
Democratising access to high quality pathology
Lorem ipsum

Reducing NHS wait times from 2 months to 2 days

Diagnexia’s AI-powered platform integrates directly with NHS systems, reducing pathology wait times from 2 months to 2 days. This seamless digital workflow accelerates accurate diagnoses for thousands, supporting NHS Trusts in achieving the 28-day Faster Diagnosis Standard while enhancing healthcare efficiency, cutting costs, and improving patient outcomes nationwide.

Read article
Read article
Reducing NHS wait times from 2 months to 2 days
Lorem ipsum

Speeding up drug development in 9/10 top pharma companies

Patholytix empowers faster, more thorough testing of 100s of drug compounds with GLP-compliant digital pathology. Our end-to-end solution enables seamless digital studies, streamlining workflows for precise, reliable insights. By accelerating pathology reporting, we help top pharma partners advance innovative therapies from preclinical studies to market with confidence and efficiency.

Read article
Read article
Speeding up drug development in 9/10 top pharma firms
Lorem ipsum

AI Improving drug safety, reducing animal burden, generating better results during preclinical research

AI-based lesion screening enhances diagnostic accuracy and minimizes subjectivity, potentially reducing the complexity and scale of studies required in the identification and characterization of new clinical candidates. In collaboration with Charles River, Deciphex has developed pre-trained models tailored for Lead Optimization and Dose Range Finding studies that provide deeper insights into candidate efficacy and reduce pathologist review time by over 20%.

Read article
Read article
AI improving drug safety, reducing animal burden and generating better results in preclinical research.
Lorem ipsum

Freeing up pathologists to focus on complex cases

Deciphex enhances diagnostic precision and speed through AI-driven quality assurance, transforming digital pathology workflows. By automating key diagnostic workflow processes, Deciphex's platforms reduce error rates and accelerate diagnoses, helping pathologists deliver more accurate insights efficiently. This approach optimizes patient outcomes and supports pharmaceutical advancements in safe, effective drug development​​​​​.

Read article
Read article
Freeing up pathologists to focus on complex cases
Lorem ipsum

Future proofing pathology

Collaborating with Novartis, Deciphex is advancing the development of next-generation foundational AI models designed to detect lesions across various species with unparalleled precision. This project leverages vast datasets and AI to support preclinical safety, ensuring early, accurate detection of potential issues and enhancing the efficiency and reliability of toxicologic assessments​​.

Read article
Read article
Future proofing pathology
Lorem ipsum

Harnessing data to power the future

With the world’s largest repository of digital slides, Deciphex is pioneering pathologist-centric foundation models. Rooted in clinical data and insights, our models redefine AI in pathology, delivering compact, agile, and diagnostically relevant tools that enhance accuracy, efficiency, and patient care—bringing the pathologist’s perspective to the forefront of AI innovation.

Read article
Read article
Lorem ipsum